This revolutionary technology was developed at the Massachusetts Institute of Technology and the device was created at the Cambridge-based start-up, Myomo, which stands for my own motion. Watch now >>
Regroup Mass Notification, an industry leading provider of mass communication solutions, today announced a strategic alliance with Code Blue…
read more…As a part of my series about strong female leaders, I had the pleasure of interviewing Clara Arroyave. Read…
read moreLow vision affects an estimated 12 million adults over 40 in the U.S., often due to issues such as…
read moreCorbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced…
read moreFor the past 25 years, the public and private sectors have worked together to establish New York City as…
read moreMyomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of…
read moreClinical-stage biotechnology company Pyramid Biosciences, Inc. announced the development of a global licensing deal for two cancer therapies worth…
read moreOne of the few venture funds making investments in South Carolina reported another record year in 2019, scaling up…
read moreAkston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a leading U.S.-based CRDMO serving the biotechnology community,…
read moreMary Sedgwick, who says she has been legally blind since 2003 due to bilateral optic neuritis, recently got the…
read more